Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Voies biliaires » Néoplasie

30. Avril 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Voies biliaires

Cholécystite - Cholélithiase

Écriture:

Page 1 de 802


	Articles 1 - 20 / 16039

	Conversion Surgery Performed Following Durvalumab Combined With Gemcitabine and Cisplatin in Cholangiocarcinoma: A Case Report. In Vivo Tagayasu Y, Yamada R, Kanemitsu K, Kondo Y, Itoyama R, Hayashi H, Komohara Y, Iwatsuki M. PMID: 40294984 [PubMed - indexed for MEDLINE]
	The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer). PLoS One Saeheng T, Tongsiri N, Na-Bangchang K. PMID: 40294042 [PubMed - indexed for MEDLINE]
	An MRI-based fusion model for preoperative prediction of perineural invasion status in patients with intrahepatic cholangiocarcinoma. World J Surg Oncol Qi Z, Yuan H, Li Q, Chen P, Li D, Chen K, Meng B, Ning P, Yu H, Li D. PMID: 40287750 [PubMed - indexed for MEDLINE]
	Establishment and validation of a novel prognostic nomogram for gallbladder cancer patients. Eur J Med Res Liu R, Zhang C, Shen Y, Wang J, Ye J, Yu J, Wang W. PMID: 40287731 [PubMed - indexed for MEDLINE]
	A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score. Curr Oncol Bayram D, Bal Ö, Karaman K, Bardakç, Demirta, Seven , Sekmek S, Perkin P, Kö, Alg, Uncu D. PMID: 40277757 [PubMed - indexed for MEDLINE]
	Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery. World J Surg Oncol Huang JC, Ma YW, Wang HX, Lang R, Jiang T. PMID: 40275372 [PubMed - indexed for MEDLINE]
	Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer: perspectives from US and Chinese payers. BMJ Open Jiang C, Zhou K, Shu P. PMID: 40268484 [PubMed - indexed for MEDLINE]
	Adjuvant chemotherapy compared with observation in patients with resected biliary tract cancer: A systematic review and meta-analysis of randomized controlled trials. PLoS One Tian L, Guo Q, Fu D, Ma X, Wang L. PMID: 40267153 [PubMed - indexed for MEDLINE]
	Preoperative glasgow prognostic score was an effective prognostic indicator in patients with biliary tract cancer. Front Immunol Liu R, Wang L, Ye J, Li X, Ma W, Xu X, Yu J, Wang W. PMID: 40264786 [PubMed - indexed for MEDLINE]
	Diagnostic accuracy of cfDNA levels in gallbladder cancer: A study using qPCR & threshold evaluation. Indian J Med Res Jindal A, Nijhawan S, Vijay U, Kaur A, Dana R. PMID: 40257142 [PubMed - indexed for MEDLINE]
	Added value of diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent cholangiocarcinoma. Nagoya J Med Sci Yamada K, Takehara Y, Ishigaki S, Ogawa H, Nishida A, Kato K, Ebata T, Mizuno T, Naganawa S. PMID: 40256005 [PubMed - indexed for MEDLINE]
	Identification of Novel Protein Biomarkers for Intrahepatic Cholangiocarcinoma by Integrating Human Plasma Proteome with Genome. J Gastrointest Cancer Chen YS, Yang WB, Li YH, Xu JY, Wei YX, Huang SM, Jiang XF, Li JH. PMID: 40240670 [PubMed - indexed for MEDLINE]
	Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review. JCO Precis Oncol Naleid N, Pawar O, Chakrabarti S, Jin Z, Mangla A, Mahipal A. PMID: 40239136 [PubMed - indexed for MEDLINE]
	Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study. Front Immunol Zheng Y, Guo J, Ren T, Ma J, Cao D. PMID: 40230857 [PubMed - indexed for MEDLINE]
	Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. Sci Rep Prajumwongs P, Titapun A, Thanasukarn V, Jareanrat A, Khuntikeo N, Namwat N, Klanrit P, Wangwiwatsin A, Chindaprasirt J, Koonmee S, Sa-Ngiamwibool P, Muangritdech N, Roytrakul S, Loilome W. PMID: 40229491 [PubMed - indexed for MEDLINE]
	CD24 and tumor budding as a prognostic variable in carcinoma gall bladder: A pilot study. J Cancer Res Ther Dubey DB, Agarwal P, Singh AK, Maurya MK, Bhalla S, Gupta V, Anand A, Gupta S, Sonkar AA. PMID: 40214364 [PubMed - indexed for MEDLINE]
	Differentiating carcinoma from benign causes of nonspecific gall bladder wall thickening: A prospective observational study on the role of multiparametric MRI and proposition of an MpMRI-based criteria. J Cancer Res Ther Mohakud S, Mishra TS, Naik S, Muduly D, Patra S, Bag ND, Kar M, Divya M, Patel RK, Tripathy TP. PMID: 40214354 [PubMed - indexed for MEDLINE]
	Radiomics in early detection of bilio-pancreatic lesions: A narrative review. Best Pract Res Clin Gastroenterol Casà C, Portik D, Abbasi AN, Miccichè F. PMID: 40210337 [PubMed - indexed for MEDLINE]
	Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer. JCO Precis Oncol Inoue K, Nakamura Y, Caughey B, Zheng-Lin B, Ueno M, Furukawa M, Kawamoto Y, Itoh S, Umemoto K, Sudo K, Satoh T, Mizuno N, Kajiwara T, Fujisawa T, Bando H, Yoshino T, Strickler JH, Morizane C, Bekaii-Saab T, Ikeda M. PMID: 40209139 [PubMed - indexed for MEDLINE]
	Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction. Eur J Gastroenterol Hepatol Qian L, Wang L, Zou Z, Luan F, Cai X, Zhou J, Zhu D, Ye J, Dai C. PMID: 40207470 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 16039

Page 1 de 802



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité